Novel mutational landscapes and expression signatures of lung squamous cell carcinoma
暂无分享,去创建一个
[1] S. Rehm,et al. Mouse bronchiolar cell carcinogenesis. Histologic characterization and expression of Clara cell antigen in lesions induced by N-nitrosobis-(2-chloroethyl) ureas. , 1991, The American journal of pathology.
[2] D. A. Kreutzer,et al. Oxidized, deaminated cytosines are a source of C --> T transitions in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[3] I. Wistuba,et al. Precursors to Pulmonary Neoplasia , 1998, Advances in anatomic pathology.
[4] M. Washington,et al. M6P/IGF2R is mutated in squamous cell carcinoma of the lung , 2000, Oncogene.
[5] J. Minna,et al. The biology of lung cancer including potential clinical applications. , 2000, Chest surgery clinics of North America.
[6] J. Lloreta,et al. Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns. , 2001, American journal of respiratory cell and molecular biology.
[7] G. Berx,et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.
[8] J. Minna,et al. Focus on lung cancer. , 2002, Cancer cell.
[9] K. Kadota,et al. Gene expression profile of normal lungs predicts genetic predisposition to lung cancer in mice. , 2003, Carcinogenesis.
[10] T. Mok,et al. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. , 2004, European journal of cancer.
[11] C. Morrison,et al. A Chemically Induced Model for Squamous Cell Carcinoma of the Lung in Mice , 2004, Cancer Research.
[12] G. Berx,et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell–cell junctions , 2005, Nucleic acids research.
[13] R. Reddel,et al. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis , 2006, International journal of cancer.
[14] B. Gunawan,et al. Assessment of molecular events in squamous and non-squamous cell lung carcinoma. , 2006, Lung cancer.
[15] S. Kaul,et al. Three faces of mortalin: A housekeeper, guardian and killer , 2007, Experimental Gerontology.
[16] H. Aburatani,et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.
[17] Igor Jurisica,et al. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.
[18] K. Cimprich,et al. ATR: an essential regulator of genome integrity , 2008, Nature Reviews Molecular Cell Biology.
[19] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[20] M. McMahon,et al. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. , 2009, Trends in biochemical sciences.
[21] Lior Pachter,et al. Sequence Analysis , 2020, Definitions.
[22] Å. Helland,et al. [Lung cancer in smokers and never-smokers]. , 2009, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[23] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[24] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[25] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[26] J. Pollack,et al. Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation. , 2010, Cancer research.
[27] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[28] S. Shi,et al. [RNA Interference targeting GRP75 decreases cisplatin resistance in human lung adenocarcinoma cell]. , 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.
[29] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[30] Iver Petersen,et al. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation. , 2011, Lung cancer.
[31] Mats Lambe,et al. Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation , 2012, Clinical Cancer Research.
[32] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[33] X. Hua,et al. Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients. , 2012, Carcinogenesis.
[34] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[35] M. Ladanyi,et al. Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations , 2012, Clinical Cancer Research.
[36] Yiping Huang,et al. Downregulation of insulin-like growth factor-binding protein 7 in cisplatin-resistant non-small cell lung cancer , 2012, Cancer biology & therapy.
[37] Jianxin Shi,et al. Multistage Analysis of Variants in the Inflammation Pathway and Lung Cancer Risk in Smokers , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[38] I. Wistuba,et al. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. , 2012, The Journal of clinical investigation.
[39] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[40] Li Ding,et al. Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.
[41] G. Prendergast,et al. IDO is a nodal pathogenic driver of lung cancer and metastasis development. , 2012, Cancer discovery.
[42] Lynette M. Smith,et al. Pathobiological Implications of MUC4 in Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[43] Elisabeth Brambilla,et al. Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers , 2013, Science Translational Medicine.
[44] R. Boldrini,et al. High-Resolution Array CGH Profiling Identifies Na/K Transporting ATPase Interacting 2 (NKAIN2) as a Predisposing Candidate Gene in Neuroblastoma , 2013, PloS one.
[45] A. Martínez-Torteya,et al. SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis , 2013, PloS one.
[46] K. Shiraishi,et al. Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer , 2013, Oncology reports.
[47] M. You,et al. Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function , 2014, Cancer Prevention Research.
[48] J. Geng,et al. IGF2R Expression is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC , 2014, Cellular Physiology and Biochemistry.
[49] Elaine Fuchs,et al. Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas , 2014, Science.
[50] Jasmin H. Bavarva,et al. Nicotine and oxidative stress induced exomic variations are concordant and overrepresented in cancer-associated genes , 2014, Oncotarget.
[51] Obi L. Griffith,et al. SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution , 2014, PLoS Comput. Biol..
[52] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[53] Yong Soo Choi,et al. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] K. Owzar,et al. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I–III Non–Small-Cell Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[55] Yee Ming Lee,et al. The impact of the Cancer Genome Atlas on lung cancer. , 2015, Translational research : the journal of laboratory and clinical medicine.
[56] Xueying Mao,et al. AB122. The structure and function of NKAIN2—a candidate tumor suppressor , 2015, International journal of clinical and experimental medicine.
[57] M. Kashyap. Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers , 2015, Tumor Biology.
[58] H. Kwok,et al. Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer. , 2015, Oncology letters.
[59] N. Beerenwinkel,et al. Tree inference for single-cell data , 2016, bioRxiv.
[60] Roland Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[61] Zhong-Qin Liang,et al. Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells , 2016, Acta Pharmacologica Sinica.
[62] P. Zhang,et al. miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2. , 2016, Oncology letters.
[63] D. Berney,et al. NKAIN2 functions as a novel tumor suppressor in prostate cancer , 2016, Oncotarget.
[64] Laurence Zitvogel,et al. Mouse models in oncoimmunology , 2016, Nature Reviews Cancer.
[65] Bruce J. Aronow,et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice , 2016, Nature.
[66] Wei Zheng,et al. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma , 2016, Oncotarget.
[67] H. Groen,et al. PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations , 2016, Oncoimmunology.
[68] J. Yim,et al. Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers , 2017, Journal of Korean medical science.
[69] Gregory Riely,et al. Investigation of patterns of nodal metastases in BRAF mutant lung cancer. , 2017, Lung cancer.
[70] Xia Li,et al. Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer , 2017, BMC Cancer.
[71] H. Qiu,et al. Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2 , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[72] J. Minna,et al. Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[73] Ashutosh Kumar Singh,et al. The see-saw of Keap1-Nrf2 pathway in cancer. , 2017, Critical reviews in oncology/hematology.
[74] I. Wistuba,et al. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[75] Yuqin Yang,et al. P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer. , 2017, Oncotarget.
[76] J. Fujimoto,et al. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.